Signaling Pathway
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
| Discription | Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 μM and 8.1 μM in carcinoma cell lines A431 and HeLa | ||
|---|---|---|---|
| Targets |
|
| Catalog Num | A14138 |
|---|---|
| Formula | C21H46NO4P |
| Molecular Weight | 407.6 |
| CAS Number | 58066-85-6 |
| SMILES | CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C |
| Synonyms | HePC |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| In vitro (25°C) | DMSO | Insoluble | |
| Water | 77 mg/mL (188.92 mM) | ||
| Ethanol | 77 mg/mL (188.92 mM) | ||
| In vivo | Saline | 28 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 24.53 mL | 122.67 mL | 245.34 mL |
| 0.5 mM | 4.91 mL | 24.53 mL | 49.07 mL |
| 1 mM | 2.45 mL | 12.27 mL | 24.53 mL |
| 5 mM | 0.49 mL | 2.45 mL | 4.91 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
